UTime (WTO) launches smartwatch with blood pressure monitoring via 6-K

UTime Limited reported the launch of a smartwatch with integrated blood pressure monitoring, expanding its product portfolio in the health technology sector.

Rhea-AI Filing Summary

UTime Limited reported the launch of a smartwatch with integrated blood pressure monitoring, expanding its product portfolio in the health technology sector. The update was disclosed via a Form 6-K and accompanied by a press release dated October 28, 2025.

This addition signals a push into health-focused wearables, aligning the company with growing demand for biometric tracking devices. The filing did not include financial details or performance metrics for the new product.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did UTime (WTO) announce in its Form 6-K?

UTime announced a smartwatch with integrated blood pressure monitoring, expanding its health technology product portfolio.

When was UTime’s smartwatch announcement made?

The press release is dated October 28, 2025.

What health feature does the new UTime smartwatch include?

It includes integrated blood pressure monitoring functionality.

Which filing reported the UTime smartwatch launch?

The launch was reported in a Form 6-K submitted as a report of a foreign private issuer.

Does the 6-K provide financial details about the smartwatch?

No financial metrics are included in the excerpt; it announces the product launch and references a press release.

How does this align with UTime’s strategy?

It expands UTime’s presence in the health technology sector through a wearable with biometric capabilities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/28/2025 - 09:45 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the Month of October 2025

Commission file number 001-40306

UTIME LIMITED

7^th Floor Building 5A

Shenzhen Software Industry Base

Nanshan, Shenzhen

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

On October 28, 2025, UTime Limited (the “Company”) issued a press release announcing the launch of a smartwatch with integrated blood pressure monitoring functionality, further expanding the Company’s product portfolio in the health technology sector. A copy of the press release is attached hereto as Exhibit 99.1.

Exhibit Index

Exhibit No.		Description
99.1		Press Release dated October 28, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	UTIME LIMITED
Dated: October 28, 2025	By:	/s/ Hengcong Qiu
	Name:	Hengcong Qiu
	Title:	Chief Executive Officer
		(Principal Executive Officer)